These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1502478)

  • 1. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug.
    Tytgat GN; Anker Hansen OJ; Carling L; de Groot GH; Geldof H; Glise H; Efskind P; Elsborg L; Karvonen AL; Ohlin B
    Scand J Gastroenterol; 1992; 27(3):175-83. PubMed ID: 1502478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists.
    Blum AL; Adami B; Bouzo MH; Brandstätter G; Fumagalli I; Galmiche JP; Hebbeln H; Hentschel E; Hüttemann W; SChütz E
    Dig Dis Sci; 1993 Mar; 38(3):551-60. PubMed ID: 8444088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance therapy with cisapride after healing of erosive oesophagitis: a double-blind placebo-controlled trial.
    McDougall NI; Watson RG; Collins JS; McFarland RJ; Love AH
    Aliment Pharmacol Ther; 1997 Jun; 11(3):487-95. PubMed ID: 9218071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride: comparison of two strategies.
    Kimmig JM
    Aliment Pharmacol Ther; 1995 Jun; 9(3):281-6. PubMed ID: 7654890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two dosing regimens of cisapride in the treatment of reflux oesophagitis.
    Schütze K; Bigard MA; Van Waes L; Hinojosa J; Bedogni G; Hentschel E
    Aliment Pharmacol Ther; 1997 Jun; 11(3):497-503. PubMed ID: 9218072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healing and prevention of relapse of reflux oesophagitis by cisapride.
    Toussaint J; Gossuin A; Deruyttere M; Hublé F; Devis G
    Gut; 1991 Nov; 32(11):1280-5. PubMed ID: 1752455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healing of grade-II and III oesophagitis through motility stimulation with cisapride.
    Lepoutre L; Van der Spek P; Vanderlinden I; Bollen J; Laukens P
    Digestion; 1990; 45(2):109-14. PubMed ID: 2190850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease.
    Hatlebakk JG; Johnsson F; Vilien M; Carling L; Wetterhus S; Thøgersen T
    Scand J Gastroenterol; 1997 Nov; 32(11):1100-6. PubMed ID: 9399390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.
    Sontag SJ; Robinson M; Roufail W; Hirschowitz BI; Sabesin SM; Wu WC; Behar J; Peterson WL; Kranz KR; Tarnawski A; Dayal Y; Berman R; Simon TJ
    Aliment Pharmacol Ther; 1997 Apr; 11(2):373-80. PubMed ID: 9146778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflux esophagitis.
    Tytgat GN; Nio CY; Schotborgh RH
    Scand J Gastroenterol Suppl; 1990; 175():1-12. PubMed ID: 1978403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisapride in the treatment of gastro-oesophageal reflux disease.
    Robertson CS; Evans DF; Ledingham SJ; Atkinson M
    Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.
    Galmiche JP; Brandstätter G; Evreux M; Hentschel E; Kerstan E; Kratochvil P; Reichel W; Schütze K; Soule JC; Vitaux J
    Gut; 1988 May; 29(5):675-81. PubMed ID: 3294124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of cisapride on symptoms and healing of gastro-oesophageal reflux disease: a review.
    Richter JE
    Scand J Gastroenterol Suppl; 1989; 165():19-27; discussion 27-8. PubMed ID: 2690321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapies for reflux esophagitis.
    Yarze JC
    N Engl J Med; 1996 Feb; 334(9):600-1. PubMed ID: 8569839
    [No Abstract]   [Full Text] [Related]  

  • 18. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study.
    Laursen LS; Havelund T; Bondesen S; Hansen J; Sanchez G; Sebelin E; Fenger C; Lauritsen K
    Scand J Gastroenterol; 1995 Sep; 30(9):839-46. PubMed ID: 8578181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance therapies for reflux esophagitis.
    Grey MR
    N Engl J Med; 1996 Feb; 334(9):600-1. PubMed ID: 8569838
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.